166 related articles for article (PubMed ID: 19477116)
1. Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Fiebrich HB; Brouwers AH; Koopmans KP; de Vries EG
Eur J Cancer; 2009 Sep; 45(13):2312-5. PubMed ID: 19477116
[TBL] [Abstract][Full Text] [Related]
2. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
[TBL] [Abstract][Full Text] [Related]
4. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
Koopmans KP; de Vries EG; Kema IP; Elsinga PH; Neels OC; Sluiter WJ; van der Horst-Schrivers AN; Jager PL
Lancet Oncol; 2006 Sep; 7(9):728-34. PubMed ID: 16945767
[TBL] [Abstract][Full Text] [Related]
5. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors.
Hoegerle S; Altehoefer C; Ghanem N; Koehler G; Waller CF; Scheruebl H; Moser E; Nitzsche E
Radiology; 2001 Aug; 220(2):373-80. PubMed ID: 11477239
[TBL] [Abstract][Full Text] [Related]
6. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
Fujishita T; Kishida M; Taki H; Shinoda C; Miyabayashi K; Fujishita M; Maruyama M; Mizushima Y; Kobayashi M
Respirology; 2007 Nov; 12(6):928-30. PubMed ID: 17986127
[TBL] [Abstract][Full Text] [Related]
7. Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
Jaffe TA; Neville AM; Bashir MR; Uronis HE; Thacker JM
Colorectal Dis; 2013 Nov; 15(11):e654-8. PubMed ID: 23910050
[TBL] [Abstract][Full Text] [Related]
8. Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.
Hoegerle S; Schneider B; Kraft A; Moser E; Nitzsche EU
Nuklearmedizin; 1999; 38(4):127-30. PubMed ID: 10392379
[TBL] [Abstract][Full Text] [Related]
9. False-negative fluorine-18-FDG PET in metastatic carcinoid.
Jadvar H; Segall GM
J Nucl Med; 1997 Sep; 38(9):1382-3. PubMed ID: 9293792
[TBL] [Abstract][Full Text] [Related]
10. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
[TBL] [Abstract][Full Text] [Related]
11. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Santhanam P; Taïeb D
Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
[TBL] [Abstract][Full Text] [Related]
12. PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
Yakemchuk VN; Jager PL; Chirakal R; Reid R; Major P; Gulenchyn KY
Nucl Med Commun; 2012 Mar; 33(3):322-30. PubMed ID: 22183015
[TBL] [Abstract][Full Text] [Related]
13. [Recurrent carcinoid tumor and 18F-DOPA PET].
Cavet M; Tenenbaum F; Hignette C; Modis C; Richard B; Faraggi M; Dousset B
Gastroenterol Clin Biol; 2010 Mar; 34(3):213-7. PubMed ID: 19864098
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
[TBL] [Abstract][Full Text] [Related]
15. Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.
Fiebrich HB; de Jong JR; Kema IP; Koopmans KP; Sluiter W; Dierckx RA; Walenkamp AM; Links TP; Brouwers AH; de Vries EG
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1854-61. PubMed ID: 21698413
[TBL] [Abstract][Full Text] [Related]
16. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
17. Lymph node staging in lung cancer using [18F]FDG-PET.
Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN
Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582
[TBL] [Abstract][Full Text] [Related]
18. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
19. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
20. A Pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-Fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome.
Dubois S; Morel O; Rodien P; Illouz F; Girault S; Cahouet A; Lacoeuille F; Brousseau M; Picquet J; Rohmer V
J Clin Endocrinol Metab; 2007 Dec; 92(12):4512-3. PubMed ID: 18056777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
